MedPath

A nutrition care support and efficacy of Levocarnitine Chloride(We change it to Levocarnitine from May 15,2015) in patients with NAFLD patients

Not Applicable
Conditions
AFLD
Registration Number
JPRN-UMIN000013760
Lead Sponsor
Osaka city Juso hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open public recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

The patients who had a diagnosis of NAFLD by liver biopsy with using echo guide in this hospital

Exclusion Criteria

Pacemaker wearing
The metal patients who enter who we have history of bone fracture, and are artificial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
hematologic biochemical test<br>(AST?ALT?gamma-GTP?TC?LDL?TG?FBS?UA?insulin?IRI?Fe?Ferritin)<br><br>Body fat measurement using CT<br>physical measurement<br>body component analysis(In Body)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath